Analyst consensus rating
LifeMD Analyst Rating: Strong Buy
Direct answer
LifeMD's consensus rating is Strong Buy.
8 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $8.13.
Forecast evidence checked October 19, 2026.
Get free LifeMD email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $2.34
- Average price target
- $8.13
- High price target
- $15.00
- Low price target
- $5.00
- Low target gap
- +113.7%
- Target upside
- +247.2%
- High target gap
- +541%
- Target range width
- 427.4%
- Consensus rating
- Strong Buy
- Analysts
- 8
- Evidence date
- October 19, 2026
- Valid through
- October 26, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for LifeMD?
LifeMD has a verified Strong Buy consensus. The same dataset has an average price target of $8.13.
How far are LifeMD's low and high targets from the recorded price?
The low target implies +113.7%, while the high target implies +541%.
How many analysts are included in LifeMD's consensus?
The verified consensus includes 8 analysts.
How is LifeMD's target upside or downside calculated?
The average target of $8.13 is divided by the recorded price of $2.34, then one is subtracted to produce +247.2%. This does not guarantee a future return.
When was LifeMD's analyst forecast verified?
The data was verified on 2026-10-19. The dataset is valid through 2026-10-26.